[Abstract Only] Study: Liquid vs. Tissue Biopsy for Detecting Acquired Resistance and Tumor Heterogeneity in Gastrointestinal Cancers
15 Sep, 2019 | 23:41h | UTCLiquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers – Nature Medicine (link to abstract – $ for full-text)
Commentary: Liquid biopsies reveal genetic alterations linked to cancer drug resistance – Broad Institute of MIT and Harvard (free)
Related Commentary on Twitter
6 words not often seen in top tier journals: "These findings have profound therapeutic implications …and highlight the potential advantages of cfDNA [liquid biopsy] over tissue biopsy in the setting of acquired [#cancer] resistance.https://t.co/92gF4OX10H @NatureMedicine pic.twitter.com/mj0NQC17SP
— Eric Topol (@EricTopol) September 10, 2019